首页> 外文期刊>Analytica chimica acta >Batch and flow-injection methods for the spectrophotometric determination of olanzapine
【24h】

Batch and flow-injection methods for the spectrophotometric determination of olanzapine

机译:分批和流动注射分光光度法测定奥氮平的方法

获取原文
获取原文并翻译 | 示例
           

摘要

An indirect batch spectrophotometric and direct flow-injection (FI) visible spectrophotometric methods have been developed for the determination of the novel anti-psychotic drug olanzapine (OLA). The batch method is based on the oxidation of olanzapine by a known excess of potassium hexacyanoferrate(III) in the presence of the mixture of sulphuric and phosphoric acids (1:1 (v/v)). The absorbance of unreacted oxidant is measured at 425 nm. The absorbance decreases linearly with increasing concentration of the assayed drug. The FI method with detection at 540 nm is based on the direct oxidation of olanzapine one of two oxidants, cerium(IV) sulphate or potassium hexacyanoferrate(III) in acidic medium. The calibration graph were linear over the range of 2.5-40mug ml~(-1) in the batch method and 0.05-300 and 0.5-250 mugml~(-1) in the FI methods, used cerium (IV) sulphate and potassium hexacyanoferrate (III) respectively. Both FI methods gave similar results in terms of precision and accuracy. The relative standard deviation (R.S.D.), was < 1%. The accuracy, obtained from recovery experiments, was 97.9-99.4%. The batch method gave slightly higher R.S.D. values (up to 2.3%) and lower values of accuracy (the recovery was between 96.5 and 96.6%). The methods developed were applied to the determination of olanzapine in a pharmaceutical product.
机译:已经开发了一种间接间歇分光光度法和直接流动注射(FI)可见光分光光度法,用于测定新型抗精神病药物奥氮平(OLA)。间歇法基于在硫酸和磷酸(1:1(v / v))混合物存在下,奥氮平被已知过量的六氰合铁酸钾(III)氧化。未反应的氧化剂的吸光度在425 nm处测量。吸光度随着所测定药物浓度的增加而线性降低。在540 nm处进行检测的FI方法基于奥氮平的两种氧化剂之一:硫酸铈(IV)或六氰合铁酸钾(III)在酸性介质中的直接氧化。批处理方法的校准曲线在2.5-40mug ml〜(-1)范围内,FI方法的校准曲线在0.05-300和0.5-250 mugml〜(-1)范围内,使用硫酸铈(IV)和六氰合铁酸钾(III)。两种FI方法在精确度和准确性方面都给出了相似的结果。相对标准偏差(R.S.D.)<1%。从回收率实验中获得的准确度为97.9-99.4%。分批方法的R.S.D.值(最高2.3%)和较低的准确性值(回收率在96.5至96.6%之间)。开发的方法用于测定药品中的奥氮平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号